BR112018012701A2 - novos compostos de 1,2,3 triazol-tiazol, processo para preparação e utilização dos mesmos - Google Patents

novos compostos de 1,2,3 triazol-tiazol, processo para preparação e utilização dos mesmos

Info

Publication number
BR112018012701A2
BR112018012701A2 BR112018012701A BR112018012701A BR112018012701A2 BR 112018012701 A2 BR112018012701 A2 BR 112018012701A2 BR 112018012701 A BR112018012701 A BR 112018012701A BR 112018012701 A BR112018012701 A BR 112018012701A BR 112018012701 A2 BR112018012701 A2 BR 112018012701A2
Authority
BR
Brazil
Prior art keywords
novel
preparation
processes
thiazole compounds
triazole
Prior art date
Application number
BR112018012701A
Other languages
English (en)
Inventor
Parul Ganju
Rajesh Sudhir Gokhale
Vivek Tirunelveli Natarajan
Dumbala Srinivasa Reddy
Balamkundu Seetharamsingh
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Publication of BR112018012701A2 publication Critical patent/BR112018012701A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

?novos compostos de 1,2,3 triazol-tiazol, processo para preparação e utilização dos mesmos?, a presente invenção divulga um novo composto de 1,2,3-triazol-tiazol de fórmula (i) ou sal farmaceuticamente aceitável do mesmo, processo para sua preparação, sua composição farmacêutica e método para o tratamento para impedir a disseminação de vitiligo ou fornecer benefício profilático aos indivíduos com predisposição a vitiligo.
BR112018012701A 2015-12-21 2016-12-20 novos compostos de 1,2,3 triazol-tiazol, processo para preparação e utilização dos mesmos BR112018012701A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN4189DE2015 2015-12-21
PCT/IN2016/050449 WO2017109793A1 (en) 2015-12-21 2016-12-20 Novel 1,2,3 triazole-thiazole compounds, process for preparation and use thereof

Publications (1)

Publication Number Publication Date
BR112018012701A2 true BR112018012701A2 (pt) 2018-12-04

Family

ID=58191512

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018012701A BR112018012701A2 (pt) 2015-12-21 2016-12-20 novos compostos de 1,2,3 triazol-tiazol, processo para preparação e utilização dos mesmos

Country Status (6)

Country Link
US (1) US10246449B2 (pt)
EP (1) EP3394054B1 (pt)
JP (1) JP6586528B2 (pt)
BR (1) BR112018012701A2 (pt)
SG (1) SG11201805237TA (pt)
WO (1) WO2017109793A1 (pt)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028383D0 (en) 2000-11-21 2001-01-03 Novartis Ag Organic compounds
US7259262B2 (en) * 2003-10-24 2007-08-21 Hoffmann-La Roche Inc. Arylazole derivatives, their manufacture and use as pharmaceutical agents
KR20080047591A (ko) * 2005-09-07 2008-05-29 플렉시콘, 인코퍼레이티드 Ｐｐａｒ 조절인자로서 사용하기 위한 1,3-이치환된 인돌유도체
WO2007087427A2 (en) * 2006-01-25 2007-08-02 Synta Pharmaceuticals Corp. Thiazole and thiadiazole compounds for inflammation and immune-related uses
EP2464635B1 (en) 2009-08-11 2015-09-16 The Scripps Research Institute Copper catalyzed cycloaddition of organic azides and 1-haloalkynes
US8377970B2 (en) * 2009-10-08 2013-02-19 Rhizen Pharmaceuticals Sa Modulators of calcium release-activated calcium channel
EP3092236B1 (en) * 2014-01-06 2020-08-26 Rhizen Pharmaceuticals S.A. Novel glutaminase inhibitors

Also Published As

Publication number Publication date
US10246449B2 (en) 2019-04-02
WO2017109793A1 (en) 2017-06-29
JP2019501168A (ja) 2019-01-17
EP3394054A1 (en) 2018-10-31
EP3394054B1 (en) 2019-11-06
JP6586528B2 (ja) 2019-10-02
US20180370962A1 (en) 2018-12-27
SG11201805237TA (en) 2018-07-30

Similar Documents

Publication Publication Date Title
CL2018002009A1 (es) Compuestos derivados de ciclopentanoperhidofenantreno, moduladores de fxr; composicion farmaceutica que comprende dichos compuestos; y su uso para el tratamiento de enfermedades colestásicas, fibróticas, hipercolesterolemia, entre otras.
SG11201806930PA (en) Novel condensed pyrimidine compound or salt thereof
PH12018501226A1 (en) Methods for treating huntingtons disease
EA202092899A1 (ru) Гетероарильные соединения для лечения болезни гентингтона
EA202092001A1 (ru) Соединения для лечения болезни гентингтона
EA201991399A1 (ru) Аминотриазолопиридиновые соединения и их применение в лечении рака
BR112019002275A2 (pt) inibidores aminopirimidina de ssaos
MX2019014514A (es) Compuestos para tratar la enfermedad de huntington.
BR112016028273A8 (pt) derivados radiorrotulados de composto de 2-amino6-fluoro-n-[5-fluoro-piridin-3-il]-pirazol[1,5-a]pirimidin3-carboxamida úteis como inibidor de atr cinase, processo para preparação do referido composto, bem como diferentes formas sólidas do mesmo, uso destas, e composição farmacêutica
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
BR112017003658A2 (pt) composto, mistura, métodos para tratamento de uma doença e para inibição de uma glicosidase, e, composição farmacêutica.
MD3601283T2 (ro) Compus inhibitor JAK pe bază de imidazo-piperidină fuzionată
BR112018008966A2 (pt) compostos inibidores de jak quinase para o tratamento de doença respiratória
BR112018015413A2 (pt) inibidores de indoleamina-2,3-dioxigenase (ido)
BR112015023948A2 (pt) composto de fórmula (i), composição farmacêutica, método para o tratamento e/ou prevenção de uma doença proliferativa e para a inibição ou a diferenciação do crescimento de uma célula tronco do câncer
BR112017023740A2 (pt) ?forma sólida de um composto, processo para a preparação de uma forma sólida, composição farmacêutica, método para o tratamento ou prevenção de doenças e utilização de uma forma sólida?
AU2016380190A8 (en) Deuterated compounds for treating cancer and related diseases and conditions, and compositions and methods thereof
BR112019025230A2 (pt) Anéis 5-5 fundidos como inibidores de c5a
CL2018003431A1 (es) Tratamiento de la enfermedad de parkinson.
BR112014029439A2 (pt) derivados de ácido salicílico, sal farmaceuticamente aceitável dos mesmos, composição dos mesmos e método de uso dos mesmos
BR112019003320A2 (pt) compostos de heteroaril carboxamida como inibidores de ripk2
EA201692260A1 (ru) Соединения 1,3,4-тиадиазола и их применение в лечении рака
BR112017003663A2 (pt) composto, composição, e, método para tratamento de infecção por hiv.
BR112018015191A2 (pt) compostos de 6,7-di-hidro-5h-pirazolo[5,1-b][1,3]oxazina-2-carboxamida
BR112016008060A8 (pt) composto, formulação farmacêutica, processo para preparar um composto de fórmula (i), método para preparação de um composto, uso do composto ou sal farmaceuticamente aceitável do mesmo

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements